NCT04647240View on ClinicalTrials.gov

Dermacyte® Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 26, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

October 15, 2025

Conditions
Venous Stasis UlcerVenous Leg Ulcer
Interventions
BIOLOGICAL

Dermacyte® Liquid (human amniotic fluid)

Subcutaneous injection into and/or around wound bed weekly

Trial Locations (9)

11042

RECRUITING

Northwell Health, Inc., New Hyde Park

24153

RECRUITING

Salem Vamc, Salem

43113

NOT_YET_RECRUITING

Brock Liden DPM, Circleville

85715

RECRUITING

Compass Medical Research Center, Tucson

93710

RECRUITING

Limb Preservation Platform, Inc., Fresno

94115

RECRUITING

Center for Clinical Research Inc., San Francisco

94117

RECRUITING

Center for Clinical Research, Inc., San Francisco

94546

RECRUITING

Center for Clinical Research, Inc., Castro Valley

02114

NOT_YET_RECRUITING

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Merakris Therapeutics

INDUSTRY

NCT04647240 - Dermacyte® Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers | Biotech Hunter | Biotech Hunter